Veranex, provider of the first purpose-built, global service platform for the medtech industry, announces that it has acquired T3 Labs, a highly reputable preclinical laboratory located in Atlanta, Georgia. This acquisition solidifies Veranex’s commitment to expanding its preclinical footprint in North America, deepening its therapeutic expertise, and providing clients with enhanced flexibility. T3 Labs is a leader in preclinical evaluation services in the United States and boasts a 33,000-square-foot facility with innovative equipment, training facilities, and state-of-the-art operating rooms dedicated to research in 12 therapeutic areas.
Read the full article: Veranex Acquires Leading Preclinical Services Provider T3 Labs //
Source: https://www.prnewswire.com/news-releases/veranex-acquires-leading-preclinical-services-provider-t3-labs-302013715.html